{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:01:51Z","timestamp":1784628111134,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hunan Provincial Natural Science Foundation Project","award":["2021JJ30511"],"award-info":[{"award-number":["2021JJ30511"]}]},{"name":"Hunan Provincial Scientific Research Project of Traditional Chinese Medicine","award":["2021062"],"award-info":[{"award-number":["2021062"]}]},{"name":"Scientific Research Fund of Hunan Provincial Education Department","award":["24A0276"],"award-info":[{"award-number":["24A0276"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10557-025-07797-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:26:39Z","timestamp":1764062799000},"page":"1255-1269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protease-activated Receptor 1 Targeted Screening of Potential Antithrombotic Compounds with Hemostatic Activity from Polygonum Amplexicaule D. Don var. Sinense Forb"],"prefix":"10.1007","volume":"40","author":[{"given":"Shiyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6994-660X","authenticated-orcid":false,"given":"Guangming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"7797_CR1","first-page":"45","volume":"8","author":"OE Dahl","year":"2012","unstructured":"Dahl OE. New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. Vasc Health Risk Manag. 2012;8:45\u201357.","journal-title":"Vasc Health Risk Manag"},{"issue":"Suppl 3","key":"7797_CR2","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.21037\/cdt.2017.09.01","volume":"7","author":"J Stone","year":"2017","unstructured":"Stone J, Hangge P, Albadawi H, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S276\u201384.","journal-title":"Cardiovasc Diagn Ther"},{"key":"7797_CR3","doi-asserted-by":"crossref","unstructured":"Green D. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism. Hematol Am Soc Hematol Educ Program. 2009;259\u201366.","DOI":"10.1182\/asheducation-2009.1.259"},{"issue":"21","key":"7797_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113176","volume":"23","author":"M Heestermans","year":"2022","unstructured":"Heestermans M, Poenou G, Duchez AC, Hamzeh-Cognasse H, Bertoletti L, Cognasse F. Immunothrombosis and the role of platelets in venous thromboembolic diseases. Int J Mol Sci. 2022;23(21):13176.","journal-title":"Int J Mol Sci"},{"key":"7797_CR5","first-page":"469","volume":"63","author":"DS Beardsley","year":"1990","unstructured":"Beardsley DS. Platelet membrane glycoproteins: role in primary hemostasis and component antigens. Yale J Biol Med. 1990;63:469\u201375.","journal-title":"Yale J Biol Med"},{"issue":"1","key":"7797_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5152\/TJAR.2019.08683","volume":"48","author":"B Al-Nasser","year":"2020","unstructured":"Al-Nasser B. Influence of tobacco smoking on perioperative risk of venous thromboembolism. Turk J Anaesthesiol Reanim. 2020;48(1):11\u20136.","journal-title":"Turk J Anaesthesiol Reanim"},{"issue":"1","key":"7797_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10557-020-07110-w","volume":"36","author":"X Sun","year":"2022","unstructured":"Sun X, Ze B, Zhang LJ, et al. Hemorrhage risk profiles among different antithrombotic regimens: evidence from a real-world analysis of postmarketing surveillance data. Cardiovasc Drugs Ther. 2022;36(1):103\u201312.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"7797_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/ATVBAHA.114.303413","volume":"35","author":"P Metharom","year":"2015","unstructured":"Metharom P, Berndt MC, Baker RI, Andrews RK. Current state and novel approaches of antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2015;35(6):1327\u201338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7797_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1182\/blood-2015-11-636472","volume":"128","author":"MT Nieman","year":"2016","unstructured":"Nieman MT. Protease-activated receptors in hemostasis. Blood. 2016;128:169\u201377.","journal-title":"Blood"},{"issue":"1","key":"7797_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11239-012-0752-4","volume":"35","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Sharma A, Mukherjee D. Par-1 antagonists: current state of evidence. J Thromb Thrombolysis. 2013;35(1):1\u20139.","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"7797_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/pca.3346","volume":"35","author":"S Huang","year":"2024","unstructured":"Huang S, He X, Huang C, et al. Thrombin-targeted screening of anticoagulant active components from polygonum amplexicaule D. Don var. sinense forb by affinity ultrafiltration coupled with UPLC-Q-TOF-MS. Phytochem Anal. 2024;35(5):1112\u201322.","journal-title":"Phytochem Anal"},{"key":"7797_CR12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5246\/jcps.2024.01.005","volume":"33","author":"G Meng","year":"2024","unstructured":"Meng G, Guo W, Fu J, et al. Promoting blood circulation and removing blood stasis of water extract from Panax zingiberensis. Chin J Med Pharm. 2024;33:46\u20139.","journal-title":"Chin J Med Pharm"},{"issue":"5","key":"7797_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0049-3848(80)90221-2","volume":"18","author":"I Reyers","year":"1980","unstructured":"Reyers I, Mussoni L, Donati MB, de Gaetano G. Failure of aspirin at different doses to modify experimental thrombosis in rats. Thromb Res. 1980;18(5):669\u201374.","journal-title":"Thromb Res"},{"issue":"17","key":"7797_CR14","first-page":"2145","volume":"38","author":"T Yang","year":"2022","unstructured":"Yang T, Jia Z, Song J, et al. Effects of different doses of Icariin on coagulation function,inflammatory factors and fibrinolytic indexes of venous thrombosis model rats. J Pract Med. 2022;38(17):2145\u201350.","journal-title":"J Pract Med"},{"issue":"07","key":"7797_CR15","first-page":"1087","volume":"32","author":"S Huang","year":"2020","unstructured":"Huang S, Mou F, Li F, et al. Potential mechanism study of herbal pair schizonepetae herba and saposhnikoviae radix against coronavirus pneumonia via network Pharmacology and molecular Docking. Nat Prod Res Dev. 2020;32(07):1087\u201398.","journal-title":"Nat Prod Res Dev"},{"issue":"10","key":"7797_CR16","first-page":"1427","volume":"45","author":"T Pan","year":"2014","unstructured":"Pan T, Zhou Z, Han Y, et al. Virtual and experimental screening of protease activated receptor 1 antagonist in plant ingredients. Chin Tradit Herb Drugs. 2014;45(10):1427\u201333.","journal-title":"Chin Tradit Herb Drugs"},{"key":"7797_CR17","doi-asserted-by":"crossref","unstructured":"Requena-Ib\u00e1\u00f1ez JA, Zafar MU, Ferrandez-Escarabajal M et al. Rationale and design of the SOTA-THROMBOSIS trial (ATRU-VI): antithrombotic activities of Sotagliflozin compared to empagliflozin. J Cardiovasc Pharmacol Published Online August 1, 2025.","DOI":"10.1097\/FJC.0000000000001747"},{"issue":"1","key":"7797_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10557-019-06932-7","volume":"34","author":"PP Wadowski","year":"2020","unstructured":"Wadowski PP, Weikert C, Pultar J, et al. Ticagrelor inhibits Toll-like and Protease-activated receptor mediated platelet activation in acute coronary syndromes. Cardiovasc Drugs Ther. 2020;34(1):53\u201363.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7797_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jff.2017.06.046","volume":"36","author":"K Agrawal","year":"2017","unstructured":"Agrawal K, Melliou E, Li X, et al. Oleocanthal-rich extra virgin olive oil demonstrates acute anti-platelet effects in healthy men in a randomized trial. J Funct Foods. 2017;36:84\u201393.","journal-title":"J Funct Foods"},{"issue":"11","key":"7797_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tibtech.2014.09.003","volume":"32","author":"X Li","year":"2014","unstructured":"Li X, Chen W, Li Z, Li L, Gu H, Fu J. Emerging microengineered tools for functional analysis and phenotyping of blood cells. Trends Biotechnol. 2014;32(11):586\u201394.","journal-title":"Trends Biotechnol"},{"key":"7797_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01417","volume":"10","author":"TJ McMahon","year":"2019","unstructured":"McMahon TJ. Red blood cell deformability, vasoactive mediators, and adhesion. Front Physiol. 2019;10:1417.","journal-title":"Front Physiol"},{"key":"7797_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1135086","volume":"14","author":"M Yan","year":"2023","unstructured":"Yan M, Gu Y, Sun H, Ge Q. Neutrophil extracellular traps in tumor progression and immunotherapy. Front Immunol. 2023;14:1135086.","journal-title":"Front Immunol"},{"issue":"6","key":"7797_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060714","volume":"14","author":"I Yoon","year":"2024","unstructured":"Yoon I, Han JH, Jeon HJ. Advances in platelet-dysfunction diagnostic technologies. Biomolecules. 2024;14(6):714.","journal-title":"Biomolecules"},{"issue":"10","key":"7797_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/CIRCRESAHA.120.315892","volume":"126","author":"F Violi","year":"2020","unstructured":"Violi F, Pastori D, Pignatelli P, Carnevale R. Nutrition, thrombosis, and cardiovascular disease. Circ Res. 2020;126(10):1415\u201342.","journal-title":"Circ Res"},{"issue":"2","key":"7797_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1042\/BST20150282","volume":"44","author":"M Cunningham","year":"2016","unstructured":"Cunningham M, McIntosh K, Bushell T, Sloan G, Plevin R. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy. Biochem Soc Trans. 2016;44(2):606\u201312.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"7797_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","volume":"15","author":"JD McFadyen","year":"2018","unstructured":"McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol. 2018;15(3):181\u201391.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"7797_CR27","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1016\/j.jtha.2023.09.013","volume":"21","author":"L Stanger","year":"2023","unstructured":"Stanger L, Yamaguchi A, Holinstat M. Antiplatelet strategies: past, present, and future. J Thromb Haemost. 2023;21(12):3317\u201328.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"7797_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-0042-1757545","volume":"49","author":"J Hartmann","year":"2023","unstructured":"Hartmann J, Curzen N. Modified thromboelastography for peri-interventional assessment of platelet function in cardiology patients: a narrative review. Semin Thromb Hemost. 2023;49(2):192\u2013200.","journal-title":"Semin Thromb Hemost"},{"key":"7797_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.549150","volume":"11","author":"H Zhang","year":"2020","unstructured":"Zhang H, Pan D, Wu X, et al. Platelet protease activated receptor 1 is involved in the hemostatic effect of 20(S)-protopanaxadiol by regulating calcium signaling. Front Pharmacol. 2020;11:549150.","journal-title":"Front Pharmacol"},{"issue":"7","key":"7797_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/09537104.2020.1859103","volume":"32","author":"DI Fern\u00e1ndez","year":"2021","unstructured":"Fern\u00e1ndez DI, Kuijpers MJE, Heemskerk JWM. Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity. Platelets. 2021;32(7):863\u201371.","journal-title":"Platelets"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07797-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:08:01Z","timestamp":1784624881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07797-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7797"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07797-9","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"9 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was approved by the Ethics Committee of Hunan University of Chinese Medicine (ethical code: HNUCM21-2501-30) and all animal experiments was complied with the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Concent of Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Concent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}